We found that six of these seven inflammatory markers (except lymphocyte percentage) significantly and partially mediated the prospective association between composite pain scores and depression incidence while controlling for covariates and multiple comparisons (bootstrapping test, P < 2.0 × 10−4; Fig. 5D), and CRP showed the greatest proportion of mediated variance. This evidence concerns the gene CRP and depressive symptom measurement.